These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23013400)

  • 1. Improved analytical methods for the detection and quantification of neutralizing antibodies to biopharmaceuticals.
    Tovey MG; Lallemand C
    Bioanalysis; 2012 Sep; 4(17):2179-90. PubMed ID: 23013400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-step assay for quantification of neutralizing antibodies to biopharmaceuticals.
    Lallemand C; Meritet JF; Blanchard B; Lebon P; Tovey MG
    J Immunol Methods; 2010 Apr; 356(1-2):18-28. PubMed ID: 20298696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunoinhibition approach to overcome the impact of pre-existing antibodies on cut point establishment for immunogenicity assessment of moxetumomab pasudotox.
    Schneider AK; Vainshtein I; Roskos LK; Chavez C; Sun B; Liang M
    J Immunol Methods; 2016 Aug; 435():68-76. PubMed ID: 27220271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Immunogenicity of Biopharmaceuticals.
    Pineda C; Castañeda Hernández G; Jacobs IA; Alvarez DF; Carini C
    BioDrugs; 2016 Jun; 30(3):195-206. PubMed ID: 27097915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of therapeutics: a matter of efficacy and safety.
    Nechansky A; Kircheis R
    Expert Opin Drug Discov; 2010 Nov; 5(11):1067-79. PubMed ID: 22827745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of cell-based assays for the detection of neutralizing antibodies to drug products: a practical approach.
    Jolicoeur P; Tacey RL
    Bioanalysis; 2012 Dec; 4(24):2959-70. PubMed ID: 23244285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoassays for Measuring Serum Concentrations of Monoclonal Antibodies and Anti-biopharmaceutical Antibodies in Patients.
    Darrouzain F; Bian S; Desvignes C; Bris C; Watier H; Paintaud G; de Vries A
    Ther Drug Monit; 2017 Aug; 39(4):316-321. PubMed ID: 28570370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of competitive ligand-binding assay and bioassay formats for the measurement of neutralizing antibodies to protein therapeutics.
    Finco D; Baltrukonis D; Clements-Egan A; Delaria K; Gunn GR; Lowe J; Maia M; Wong T
    J Pharm Biomed Anal; 2011 Jan; 54(2):351-8. PubMed ID: 20863644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of neutralizing antibodies to erythropoietin by inhibition of rHuEPO-stimulated EGR1 gene expression in the UT-7/EPO cell line.
    Ferguson J; Bird C; Wadhwa M; Burns C
    J Immunol Methods; 2013 Jan; 387(1-2):191-8. PubMed ID: 23142458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and optimization of a cell-based neutralizing antibody assay using a sample pre-treatment step to eliminate serum interference.
    McCutcheon KM; Quarmby V; Song A
    J Immunol Methods; 2010 Jun; 358(1-2):35-45. PubMed ID: 20361968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of design of experiments (DOE) in the development and validation of a cell-based bioassay for the detection of anti-drug neutralizing antibodies in human serum.
    Chen XC; Zhou L; Gupta S; Civoli F
    J Immunol Methods; 2012 Feb; 376(1-2):32-45. PubMed ID: 22119514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a bridging ELISA for detection of anti-erythropoietin binding antibodies and a cell-based bioassay for neutralizing antibodies in human sera.
    Shin SK; Ha SK; Lee KW; Yoo TH; Yun SR; Yoon SH; Kim SJ; Lee SK; Heo TH
    J Pharm Biomed Anal; 2010 Jun; 52(2):289-93. PubMed ID: 20133098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a human antibody reference panel against erythropoietin suitable for the standardization of ESA immunogenicity testing.
    Mytych DT; Barger TE; King C; Grauer S; Haldankar R; Hsu E; Wu MM; Shiwalkar M; Sanchez S; Kuck A; Civoli F; Sun J; Swanson SJ
    J Immunol Methods; 2012 Aug; 382(1-2):129-41. PubMed ID: 22634015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry.
    Bronsema KJ; Bischoff R; van de Merbel NC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():1-14. PubMed ID: 22426285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New virologic reagents for neutralizing antibody assays.
    Ochsenbauer C; Kappes JC
    Curr Opin HIV AIDS; 2009 Sep; 4(5):418-25. PubMed ID: 20048706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and optimization of neutralizing antibody assays to monitor clinical immunogenicity.
    Civoli F; Kroenke MA; Reynhardt K; Zhuang Y; Kaliyaperumal A; Gupta S
    Bioanalysis; 2012 Nov; 4(22):2725-35. PubMed ID: 23210655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of neutralizing interleukin-17 antibodies in autoimmune polyendocrinopathy syndrome-1 (APS-1) patients using a novel non-cell based electrochemiluminescence assay.
    Cludts I; Meager A; Thorpe R; Wadhwa M
    Cytokine; 2010 May; 50(2):129-37. PubMed ID: 20116277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and establishment of specifications for biopharmaceuticals.
    Davis GC; Riggin RM
    Dev Biol Stand; 1997; 91():49-54. PubMed ID: 9413683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate mammalian expression systems for biopharmaceuticals.
    Werner RG; Noé W; Kopp K; Schlüter M
    Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunogenicity of biopharmaceuticals. Lessons learned and consequences for protein drug development.
    Patten PA; Schellekens H
    Dev Biol (Basel); 2003; 112():81-97. PubMed ID: 12762507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.